OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: RESULTS OF 3-YEAR FOLLOW-UP STUDY

Antmen, B.Karakas, Z.Kupesiz, O. A.Sasmaz, I.Kurtoglu, E.Aydogan, G.Salcioglu, Z.2024-04-242024-04-2420150390-6078https://hdl.handle.net/11468/2316920th Congress of European-Hematology-Association -- JUN 11-14, 2015 -- Vienna, AUSTRIA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: RESULTS OF 3-YEAR FOLLOW-UP STUDYOUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: RESULTS OF 3-YEAR FOLLOW-UP STUDYConference Object100292292WOS:000361204902241Q1